Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-06-05
1995-10-17
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142272, 514255, 514379, 514389, 514396, 514912, A61K 3155, A61K 31535, A61K 31495, A61K 3142
Patent
active
054591333
ABSTRACT:
This invention is directed to treatment for increasing the accommodative ability of the eye, for the purpose of decreasing the severity of clinically evident presbyopia, an age-related loss of accommodative ability. The compounds and methods of the invention act by decreasing the tone of parts of the ciliary muscle which act to decrease accommodation, thereby increasing the contractile force of the remaining ciliary muscle, with resultant increased accommodative function.
REFERENCES:
patent: 4443441 (1984-04-01), Galin
patent: 4459292 (1984-07-01), Andermann et al.
patent: 4496558 (1985-07-01), DeMarinis et al.
patent: 4797422 (1989-01-01), Testa
T. Miwa et al.; "The Effect of Sympathomimetic and Sympatholytic Drugs Upon Resting Point of Accomodation"; 1988, pp. 1235-1241; Acta Soc. Ophthalmol. Jpn. vol. 92, No. 7.
G. Nyberg; "The Influence of Beta-Adrenoceptor Agonists on Accomodation of the Lens"; 1976; pp. 493-495; Clin. Exp. Pharmacol Physiol.; vol. 3, No. 5.
T. Yoshitomi et al., "Pre-Synaptic Actions of Noradrenaline on the Dog Ciliar Muscle Tissue"; 1986; pp. 119-127; Exp. Eye Res. vol. 43, No. 1.
Hurwitz, B., et al., "The Effects of the Sympathetic Nervous System on Accommodation", Arch Ophthal, 87, Jun. 1972, pp. 668-674.
Cogan, D., "Accommodation and the Autonomic Nervous System", Arch Ophthal., vol. 18, (1937), pp. 739-766.
Stephens, K., "Effect of the Sympathetic Nervous System on Accommodation", Amer. J. Optometry & Physiol. Optics, vol. 62, No. 6, pp. 402-406 (1985).
Eskridge, J., "Review of Ciliary Muscle Effort in Presbyopia", Amer. J. Optometry & Physiol. Optics, vol. 61, No. 2, pp. 133-138, (1984).
Coleman, A., "Cardiovascular and Intraocular Pressure Effects and Plasma Concentrations of Apraclonidine", Arch Ophthalmol., vol. 108, Sep. 1990.
Robin, A., "Effects of ALO 2145 on Intraocular Pressure Following Argon Laser Trabeculoplasty", Arch Ophthalmol., vol. 105, May 1987, pp. 646-650.
Jampel,H., "Apraclonidine", Arch Ophthalmol, vol. 106, Aug. 1988, pp. 1069-1073.
Abrams, D., "The Safety and Efficacy of Topical 1% ALO 2145 . . . ", Arch Ophthalmol, vol. 105, Sep. 1987, pp. 1205-1207.
Samson, C. R., "Safety and toleration of oxymetazoline ophthalmic solution", Pharmatherapeutica, vol.2, No. 6, 1980, pp. 347-352.
Duzman, E., "Topically Applied Oxymetazoline", Arch Ophthalmol., vol. 101, Jul. 1983, pp. 1122-1126.
Duzman, E., "Efficacy and Safety of Topical Oxymetazoline in Treating Allergic and Environmental Conjunctivitis", Ann. Ophthalmol 1986; 18: 28-31.
Abelson, M., "Tolerance and Absence of Rebound Vasodilation Following Topical Ocular Decongestant Usage", pp. 1364-1367. 1984.
Hurwitz, P., "Uses of Naphazoline (Privine) In Ophthalmology", Arch Ophthalmol 1950; 43; pp. 712-717.
Podos, S., "Experimental compounds to lower intraocular pressure" Australian & New Zealand J. Ophthalmology, 1989; 17(20, pp. 129-135).
Potter, D., "Medetomidine-Induced Alterations of Intraocular Pressure . . . ", Investigative Ophthal. & Visual Science, vol. 32, No. 10, Sep. 1991, pp. 2799-2805.
Rosenfield, M., "The influence of alpha-adrenergic agents on tonic accommodation", Current Eye Research, vol. 9, No. 3, 1990, pp. 267-272.
Serle, J. et al., "Selective .alpha.2-Adrenergic Agonists B-HT 920 and UK14304-18", Arch Ophthalmol, vol. 109, Aug. 1991, pp. 1158-1162.
Zetterstrom, C. et al. "Pharmacological Characterization of Human Ciliary Muscle Adrenoceptors In Vitro", Exp. Eye Res. 1988 46: pp. 421-430.
Vartiainen, J. et al., "Dexmedetomidine-Induced Ocular Hypotension in Rabbits With Normal or Elevated Intraocular Pressures", Investigative & Ophthalmol. & Visual Science, vol. 33, No. 6, May 1992, pp. 2019-2023.
Gilmartin, B. et al., "Pharmacological Effects on Accommodative Adaption", Optometry and Vision Science, vol. 69, No. 4, pp. 276-282 (1992).
Gilmartin, B., "A Review of the Role of Sympathetic Innervation of the Ciliary Muscle in Ocular Accommodation", Ophthal. Physiol. Opt. vol. 6, No. 1, pp. 23-37, 1986.
Eskridge, J. B., "Ciliary Muscle effort in presbyopia", J. Optom. Arch, Am. Acad. Opt., Aug, (1972).
Montgomery, D., et al., "Pupil Dilatation with Tropicamide. The Effects on Acuity, Accommodation and Refraction", Eye (1989) 3: pp. 845-848.
Garner, et al., "The Effect of Phenylephrine Hydrochloride on the Resting Point of Accommodation", Investigative Opth. and Visual Science, vol. 24/4, Apr., 1983.
C. Flugel, et al., "Histochemical Differences Within the Ciliary Muscle and its Function in Accommodation", Ex. Eye Res. (1990: 50, pp. 219-226.
Erickson-Lamy, et al., "Dissociation Between the Effect of Aceclidine on Outflow Facility and Accommodation"; 1990 Academic Press Limited.
Diane D., et al., "Ocular Bio Distrib. of Clonidine After Topical Appl. with Ophthalmic Rods or Solution", Jnl. of Ocular Pharma., vol. 5, No. 2, 1989.
van Pinxteren, P. C. M., "Hypotensive Effects after Topical and Intra-Arterial Administration of .alpha.-Adrenergic Agonists in Isolated Perfused Rabbit Eyes", Ophthalmic Res., 17: pp. 349-353 (1985).
Elena, et al., "Alph.sub.2 -Adrenergic Receptors in Rat and Rabbit Eye: A Tritium-Sensitive Film Autoradiography", Ophthalmic Res., 1989; 21:309-314.
Bito, Laszlo, Z., "Presbyopia", Arch Ophthalmol, vol. 106, Nov. 1988.
Rubin, et al., "Pharmacodynamic Studies with a Specific .alpha.-Adrenoceptor Agonist (BHT-933) in Man Jrnl. of Cardio. Pharmacology", pp. 527-530, 1982.
Adler-Grinberg, D., "Questioning Our Classical Understanding of Accommodation and Presbyopia", Am. J. Optom. & Physiol. Optics, vol. 63, No. 7, pp. 571-580 (1986).
Fisher, R. F., "The Mechanics of Accommodation in Relation to Presbyopia", Eye (1988), 2, pp. 646-649.
Gilmartin, B., et al., "The Relationship between Tonic Accommodation and Ciliary Muscle Innervation", Invest. Ophthal. & Visual Science, Jul. 1985, vol. 26, pp. 1024-1028.
Koretz, J. F., et al., "Accommodation and Presbyopia in the Human Eye-Aging of the Anterior Segment", Vision Res., vol. 29, No. 12, pp. 1685-1692, 1989.
Lograno, M. D., et al., "Receptor-responses in fresh human ciliary muscle", Br. J. Pharmac. (1986), 87, pp. 379-385.
van Alphen, "The adrenergic receptors of the intraocular muscles of the human eye", Investigative Ophthalmology, vol. 15, No. 6, pp. 502-505 (Jun. 1976).
Wand, M., et al., "Thymoxamine Hydrochloride: An Alpha-adrenergic Blocker", Survey of Ophthalmology, vol. 25, No. 2, Sep.-Oct. 1980, pp. 75-84.
Zetterstrom, C., "The effects of thymoxamine, phenylephrine and cyclopentolate on the accommodative process in man", Acta Ophthalmologica, 65 (1987) pp. 699-704.
Stark, L. 1988, "Presbyopia in light of accommodation", Am. J. Optom. Physiol. Opt. 65: pp. 407-416.
Gilmartin, B., et al., "The Effect of Timolol Maleate on Tonic Accommodation . . . ", Investigative Ophthalmology & Visual Science, vol. 25, Jun. 1984, pp. 763-770.
Fay Zohreh
Telor Ophthalmic Pharmaceuticals, Inc.
LandOfFree
Methods and products for treating presbyopia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and products for treating presbyopia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and products for treating presbyopia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597416